Literature DB >> 11306686

Antimitogenic actions of organic nitrates are potentiated by sildenafil and mediated via activation of protein kinase A.

M T Osinski1, B H Rauch, K Schrör.   

Abstract

Migration and proliferation of vascular smooth muscle cells (SMC) in response to platelet-derived growth factor (PDGF) and other mitogens play an important role in restenosis after coronary angioplasty. Elevation of both cAMP and cGMP has been shown to inhibit SMC mitogenesis. The aim of this study was to examine the antimitogenic actions of organic nitrates and sildenafil and to clarify the role of cyclic nucleotide-dependent protein kinases (PKA, PKG) in this action. Organic nitrates [glycerol trinitrate (GTN), isosorbide 5'-mononitrate (ISMN), pentaerythrityl-tetranitrate (PETN)] and the PDE5 inhibitor sildenafil reduced PDGF-induced DNA synthesis, measured by ((3)H]thymidine incorporation. GTN, ISMN, and PETN acted synergistically with sildenafil (1 microM) on inhibition of PDGF-induced DNA synthesis, increase of intracellular cyclic nucleotides, and vasodilator-stimulated phosphoprotein phosphorylation. The highly selective PKA inhibitor PKI abolished these actions of sildenafil and organic nitrates, whereas the PKG inhibitors KT5823 and (Rp)-8-pCPT-cGMPS had no effect. In addition, selective activation of PKG without inhibition of PDE3 by the cGMP analog 8-pCPT-cGMP (100 microM) had no antimitogenic effect. The data suggest that 1) organic nitrates and sildenafil exert antimitogenic actions by activation of PKA via inhibition of PDE3, but not by activation of PKG and 2) that antimitogenic effects of organic nitrates are potentiated by sildenafil at therapeutic plasma levels.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11306686     DOI: 10.1124/mol.59.5.1044

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  15 in total

1.  Phosphodiesterase 3A (PDE3A) deletion suppresses proliferation of cultured murine vascular smooth muscle cells (VSMCs) via inhibition of mitogen-activated protein kinase (MAPK) signaling and alterations in critical cell cycle regulatory proteins.

Authors:  Najma Begum; Steven Hockman; Vincent C Manganiello
Journal:  J Biol Chem       Date:  2011-06-01       Impact factor: 5.157

2.  Profiling of functional phosphodiesterase in mesangial cells using a CRE-SEAP-based reporting system.

Authors:  Ying Zhu; Jian Yao; Yiman Meng; Ayumi Kasai; Nobuhiko Hiramatsu; Kunihiro Hayakawa; Takashi Miida; Masayuki Takeda; Masahiko Okada; Masanori Kitamura
Journal:  Br J Pharmacol       Date:  2006-06-05       Impact factor: 8.739

Review 3.  Role of PDE3A in regulation of cell cycle progression in mouse vascular smooth muscle cells and oocytes: implications in cardiovascular diseases and infertility.

Authors:  Najma Begum; Weixing Shen; Vincent Manganiello
Journal:  Curr Opin Pharmacol       Date:  2011-11-01       Impact factor: 5.547

4.  Irsogladine maleate potentiates the effects of nitric oxide on activation of cAMP signalling pathways and suppression of mesangial cell mitogenesis.

Authors:  J Yao; Y Zhu; W Sun; N Sawada; N Hiramatsu; M Takeda; M Kitamura
Journal:  Br J Pharmacol       Date:  2007-04-16       Impact factor: 8.739

Review 5.  Regulation of phosphodiesterase 3 and inducible cAMP early repressor in the heart.

Authors:  Chen Yan; Clint L Miller; Jun-ichi Abe
Journal:  Circ Res       Date:  2007-03-02       Impact factor: 17.367

6.  Angiotensin II increases phosphodiesterase 5A expression in vascular smooth muscle cells: a mechanism by which angiotensin II antagonizes cGMP signaling.

Authors:  Dongsoo Kim; Toru Aizawa; Heng Wei; Xinchun Pi; Sergei D Rybalkin; Bradford C Berk; Chen Yan
Journal:  J Mol Cell Cardiol       Date:  2004-12-08       Impact factor: 5.000

Review 7.  Therapeutic potential of PDE modulation in treating heart disease.

Authors:  Walter Knight; Chen Yan
Journal:  Future Med Chem       Date:  2013-09       Impact factor: 3.808

8.  Sildenafil inhibits chronically hypoxic upregulation of canonical transient receptor potential expression in rat pulmonary arterial smooth muscle.

Authors:  Wenju Lu; Pixin Ran; Dandan Zhang; Gongyong Peng; Bing Li; Nanshan Zhong; Jian Wang
Journal:  Am J Physiol Cell Physiol       Date:  2009-11-04       Impact factor: 4.249

Review 9.  Phosphodiesterase inhibition in heart failure.

Authors:  Matthew Movsesian; Josef Stehlik; Fabrice Vandeput; Michael R Bristow
Journal:  Heart Fail Rev       Date:  2008-12-19       Impact factor: 4.214

10.  Multidrug resistance-associated protein 4 regulates cAMP-dependent signaling pathways and controls human and rat SMC proliferation.

Authors:  Yassine Sassi; Larissa Lipskaia; Grégoire Vandecasteele; Viacheslav O Nikolaev; Stéphane N Hatem; Fleur Cohen Aubart; Frans G Russel; Nathalie Mougenot; Cédric Vrignaud; Philippe Lechat; Anne-Marie Lompré; Jean-Sébastien Hulot
Journal:  J Clin Invest       Date:  2008-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.